Nutrition 21 settles Chromax patent lawsuit

Nutrition 21 settles Chromax patent lawsuit

Settlement ends a patent and trademark infringement lawsuit against SuperNutrition for its use of the Chromax trademark and chromium polynicotinate in its multivitamins.

JDS Therapeutics LLC and its subsidiary, Nutrition 21 LLC, announced that they have entered into a confidential settlement and license agreement with SuperNutrition Life-Extension Research Inc.

The settlement ends a patent and trademark infringement lawsuit brought by Nutrition 21 against SuperNutrition in the Southern District of New York related to SuperNutrition’s use of Nutrition 21’s Chromax trademark and chromium polynicotinate in its branded multivitamin products. The terms of the settlement are confidential, however, in conjunction with the settlement, SuperNutrition has agreed to license Nutrition 21’s various chromium polynicotinate patents and its Chromax and Niachrome trademarks and utilize Nutrition 21’s Niachrome brand of chromium polynicotinate for its applicable formulation needs.

Gregg Bresner, chief financial officer of Nutrition 21, stated, “We are delighted that we were able to reach a customer-driven solution with respect to our dispute with SuperNutrition. SuperNutrition has been an innovative company in the market for decades and we are excited to provide Niachrome to SuperNutrition for use in its branded family of multivitamin products. We believe this reaffirms the strength of Nutrition 21’s trademarks, and its patent portfolio which covers compositions and uses of a number of our products, including our Niachrome chromium polynicotinate.”

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish